About 30,000 Trademarks found for “innovative cellular therapeutics holdings limited”

The mark consists of a stylized butterfly in the combination of blue, green and orange on the left of three stylized letters "ICT" in dark gray. The stylized butterfly and the letters "ICT" are above the phrase "Innovative Cellular Therapeutics" in dark gray.

collection, testing, processing, storage and retrieval of blood, blood components, tissue, and stem cells for medical research, treatment and diagnostics; providing medical information and written materials distributed therewith

CELLULAR THERAPEUTICS

The mark consists of a white background with the connected initials "GHL", with the "GH" in red and the lower part of the "L" in black, above "GRIOT HOLDINGS" in black and with "LIMITED" on the bottom in red with black horizontal lines on each side.

"THERAPEUTICS"

"CELL"

Cells for medical or clinical use for the treatment of a variety of human diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders; pharmaceutical preparations of engineered erythroid cells for medical or clinical use for the treatment of a variety of human diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders; engineered erythroid cells for medical or clinical use for the treatment of a variety of human diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders; none of the foregoing used as vitamin-mineral supplements or for animals

The mark consists of numerous adjacent but unattached squares with rounded edges, which combine to form a spherical shape that appears to be three-dimensional. The top and bottom portions of the spherical shape are truncated, so that the sides are rounded, and the top and bottom are flat. The word "lime" appears in lower case letters to the right of the spherical shape. Below and slightly to the left of the word "lime" is the word "cellular" in lower case letters.

The mark consists of the large stylized word "CELLIGENICS" above the smaller stylized lower-case wording "ENABLING CELLULAR THERAPEUTICS", all beneath a triangular design with rounded corners.

The mark consists of the large stylized word "CELLIGENICS" above the smaller stylized lower-case wording "ENABLING CELLULAR THERAPEUTICS", all beneath a triangular design with rounded corners.

Color is not claimed as a feature of the mark.

Pharmaceutical preparations for the treatment and prevention of inflammatory and degenerative neuro-vascular diseases; Pharmaceutical preparations for the treatment of inflammatory and degenerative neuro-vascular diseases; Stem cells for medical purposes